Rozanolixizumab approved to treat adult patients with the autoimmune disease generalised myasthenia gravis

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes m…

Tees Valley Combined Authority: Mayor’s initial response to the publication of the Tees Valley Review

Letter from Ben Houchen, Tees Valley Mayor, in response to the to the publication of the Tees Valley Review.

Tees Valley Combined Authority: Secretary of State letter to the Tees Valley Mayor regarding the Tees Valley Review

Letter from Michael Gove MP, Secretary of State, to the Tees Valley Mayor, regarding his initial response to the Tees Valley Review.

Liverpool City Council: Letter to Chief Executive (7 March 2024)

Letter to the Chief Executive announcing an amendment to the scope of the intervention at Liverpool City Council through newly issued Directions.

Liverpool City Council: Letter to Commissioners (7 March 2024)

Letter to the Commissioners at Liverpool City Council informing them of changes to their functions.